Replimune Group, Inc.
REPL institutional ownership changes in Q2 2026: 73 institutions opened or added positions, 51 trimmed or exited. REPL (Replimune Group, Inc.) is held by 107 institutional investors as of Q2 2026. Top institutional shareholders: Baker Bros. Advisors LP ($122.3M), BlackRock, Inc. ($99.2M), RTW Investments, LP ($82M). Institutions were buying, on balance.
Who's Trading
Latest move
Source dates: Price Nov 5, 2026 · Insiders Nov 3, 2026 · Activists Aug 14, 2026 · Congress none
Top Holders
| Action | ||||||
|---|---|---|---|---|---|---|
Unchanged | 11M | $122.3M | 0.6% | +53.56% | 0 | |
Increased | 9M(+43.6%) | $99.2M | 0.0% | +91.13% | 40 | |
Increased | 7.4M(+0.7%) | $82M | 0.7% | +211.54% | 42 | |
Increased | 4.5M(+99.4%) | $50.3M | 0.0% | +113.68% | 47 | |
Increased | 4.4M(+17.4%) | $49.2M | 0.0% | +95.79% | 34 | |
Increased | 2.9M(+5.0%) | $32.1M | 0.0% | +164.35% | 30 | |
Increased | 2.6M(+904.4%) | $28.4M | 0.0% | +92.46% | 46 | |
Increased | 2.3M(+442.5%) | $25.7M | 0.0% | +107.65% | 46 | |
Unchanged | 2.1M | $23.7M | 0.2% | +264.92% | 0 | |
Increased | 2M(+13.0%) | $22.5M | 0.0% | +36.54% | 32 | |
Decreased | 1.8M(-23.4%) | $19.8M | 0.0% | +111.60% | 0 | |
Decreased | 1.6M(-80.0%) | $17.9M | 0.0% | -3.62% | 0 | |
Decreased | 1.3M(-19.9%) | $14.1M | 0.0% | +226.91% | 0 | |
Increased | 1.1M(+94.1%) | $12.5M | 0.0% | +147.79% | 44 | |
New | 973,496 | $10.8M | 0.0% | +86.54% | 38 | |
Decreased | 929,375(-54.6%) | $10.3M | 0.0% | +138.47% | 0 | |
Increased | 821,958(+173.2%) | $9.1M | 0.0% | +118.77% | 45 | |
Increased | 784,233(+96.7%) | $8.7M | 0.0% | +112.36% | 44 | |
Increased | 783,873(+73.5%) | $8.7M | 0.0% | +142.86% | 41 | |
Increased | 724,244(+279.3%) | $8M | 0.0% | +93.74% | 44 |
Showing 1-20 of 130
REPLReplimune Group, Inc.Continue exploring
Other Healthcare stocks held by institutions
UNHUnitedHealth Group Incorporated
LLYEli Lilly and Company
TMOThermo Fisher Scientific Inc
JNJJohnson & Johnson
DHRDanaher Corporation
ISRGIntuitive Surgical, Inc.
MRKMerck & Company, Inc.
ABBVAbbVie Inc.
BSXBoston Scientific Corporation
ABTAbbott LaboratoriesQuestions investors ask about REPL
Who owns REPL?
107 institutional investors held REPL on June 30, 2026, led by Baker Bros. Advisors LP ($122.3M), BlackRock, Inc. ($99.2M) and RTW Investments, LP ($82M).
How many hedge funds hold REPL?
107 institutional investors reported REPL in their 13F filings for the quarter ended June 30, 2026, $770.1M in all. 7 of them are rated Elite.
Are institutions buying or selling REPL?
Buying, on balance. In Q2 2026, 73 institutions opened or added to positions in REPL and 51 institutions trimmed or exited.
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer